A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
The California Future Health Workforce Commission will produce recommendations intended to meet the demand for medical professionals in a state with a growing and increasingly diverse population.
A program that provides $400 million in federal funding for the visits expires next month. Advocates and providers hope it will be reauthorized with a higher level of funding — but some worry that might not happen.
As more patients receive hospice care at home, some of the powerful, addictive drugs they’re prescribed are ending up in the wrong hands.
When Anthem Blue Cross pulls out of the individual market next year, about 60,000 Covered California enrollees, plus others who buy insurance outside of the exchange, will have only one health plan in their areas.
Oregon court says Alzheimer’s patient Nora Harris must be spoon-fed. But her husband says she never wanted to live like this.
The state health insurance exchange made three multimillion-dollar decisions Thursday that were motivated by the lack of clarity from the federal government on key health policy issues.
Sign Up For Our Email Newsletter
Stay informed by signing up for California Healthline's Daily Edition and other emails.